Evidence map›Paper›PMID 34484688›Full record

ArticleF1000Research2021

ASaiM-MT: a validated and optimized ASaiM workflow for metatranscriptomics analysis within Galaxy framework.

Subina Mehta, Marie Crane, Emma Leith, Bérénice Batut, Saskia Hiltemann, Magnus Ø Arntzen, Benoit J Kunath, Phillip B Pope, Francesco Delogu, Ray Sajulga and 4 more

Abstract read
In one paragraph

Article in F1000Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Integrative meta-omics in Galaxy and beyond.Environmental microbiome · 2023
    Article
  4. Article
  5. Galaxy Training: A powerful framework for teaching!PLoS computational biology · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Subina MehtaUniversity of Minnesota, Twin Cities, MN, 55455, USA.ORCID 0000-0001-9818-0537
Marie CraneUniversity of Minnesota, Twin Cities, MN, 55455, USA.ORCID 0000-0002-5090-2163
Emma LeithUniversity of Minnesota, Twin Cities, MN, 55455, USA.
Bérénice BatutDepartment of Bioinformatics, University of Freiburg, Georges-Köhler-Allee 106, Freiburg, Germany.ORCID 0000-0001-9852-1987
Saskia HiltemannDepartment of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
Magnus Ø ArntzenNorwegian University of Life Sciences, Ås, 1430, Norway.
Benoit J KunathNorwegian University of Life Sciences, Ås, 1430, Norway.ORCID 0000-0002-3356-8562
Phillip B PopeNorwegian University of Life Sciences, Ås, 1430, Norway.
Francesco DeloguNorwegian University of Life Sciences, Ås, 1430, Norway.
Ray SajulgaUniversity of Minnesota, Twin Cities, MN, 55455, USA.
Praveen KumarUniversity of Minnesota, Twin Cities, MN, 55455, USA.
James E JohnsonUniversity of Minnesota, Twin Cities, MN, 55455, USA.
Timothy J GriffinUniversity of Minnesota, Twin Cities, MN, 55455, USA.ORCID 0000-0001-6801-2559
Pratik D JagtapUniversity of Minnesota, Twin Cities, MN, 55455, USA.ORCID 0000-0003-0984-0973

Funding

Expanding multiplexed kinase biosensor analysis to SWATH-MS (Part 2 of 2)U24CA199347 · NCI · UNIVERSITY OF MINNESOTA · PI GRIFFIN, TIMOTHY J. · 2016 to 2019
$2.4M
NCI NIH HHS U24 CA199347
6 · The paper itself

Abstract

The Earth Microbiome Project (EMP) aided in understanding the role of microbial communities and the influence of collective genetic material (the 'microbiome') and microbial diversity patterns across the habitats of our planet. With the evolution of new sequencing technologies, researchers can now investigate the microbiome and map its influence on the environment and human health. Advances in bioinformatics methods for next-generation sequencing (NGS) data analysis have helped researchers to gain an in-depth knowledge about the taxonomic and genetic composition of microbial communities. Metagenomic-based methods have been the most commonly used approaches for microbiome analysis; however, it primarily extracts information about taxonomic composition and genetic potential of the microbiome under study, lacking quantification of the gene products (RNA and proteins). On the other hand, metatranscriptomics, the study of a microbial community's RNA expression, can reveal the dynamic gene expression of individual microbial populations and the community as a whole, ultimately providing information about the active pathways in the microbiome.  In order to address the analysis of NGS data, the ASaiM analysis framework was previously developed and made available via the Galaxy platform. Although developed for both metagenomics and metatranscriptomics, the original publication demonstrated the use of ASaiM only for metagenomics, while thorough testing for metatranscriptomics data was lacking.  In the current study, we have focused on validating and optimizing the tools within ASaiM for metatranscriptomics data. As a result, we deliver a robust workflow that will enable researchers to understand dynamic functional response of the microbiome in a wide variety of metatranscriptomics studies. This improved and optimized ASaiM-metatranscriptomics (ASaiM-MT) workflow is publicly available via the ASaiM framework, documented and supported with training material so that users can interrogate and characterize metatranscriptomic data, as part of larger meta-omic studies of microbiomes.

Indexed as

MetagenomicsMicrobiotaHigh-Throughput Nucleotide SequencingHumansMetagenomeWorkflowfunctional analysisGalaxymetatranscriptomicsmicrobiome

Identifiers

PMID34484688
PMCPMC8383124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.